Yes but you need to be very careful trying to compare results between different studies, however there is a remarkable consistency with Aflibercept achieving around 50% 20/32-20/40...
But the improvement to 48.6% from 34.5% by adding OPT302 to Lucentis is impressive. That's why we're all here. Assuming we're lucky enough to get success in the first trial with Eyelea we should get at least as good a result with the second one. Fingers crossed but nothing is guarranteed. I've been shocked a few times, but then so has big pharma. I'll be cracking the champers if this one comes home, so will Mr Mutton.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024, page-39
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $695.5M |
Open | High | Low | Value | Volume |
57.5¢ | 57.5¢ | 55.0¢ | $706.9K | 1.260M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 79437 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 174437 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29437 | 0.555 |
2 | 47582 | 0.550 |
1 | 29437 | 0.545 |
2 | 7254 | 0.540 |
4 | 21773 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.570 | 174437 | 2 |
0.575 | 59437 | 2 |
0.580 | 38513 | 7 |
0.590 | 15500 | 1 |
0.595 | 103600 | 2 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |